Cognitive impairment in progressive supranuclear palsy is associated with tau burden
暂无分享,去创建一个
D. Dickson | R. Uitti | Z. Wszolek | N. Graff-Radford | M. Baker | K. Josephs | J. Ahlskog | M. Sanchez-Contreras | A. Parks | S. Koga | J. V. van Gerpen | K. Kasanuki | R. Rademakers | D. Dickson | Monica Sanchez-Contreras | Matthew C. Baker
[1] Stewart G. Armitage,et al. An Analysis of Certain Psychological Tests Used for the Evaluation of Brain Injury , 2017 .
[2] D. Dickson,et al. Reply re: “Profile of cognitive impairment and underlying pathology in multiple system atrophy” , 2017, Movement disorders : official journal of the Movement Disorder Society.
[3] A. Antonini,et al. Cognitive impairment in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.
[4] Murray Grossman,et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.
[5] J. Morris,et al. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease , 2017, Neurology.
[6] D. Dickson,et al. Profile of cognitive impairment and underlying pathology in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.
[7] W. Poewe,et al. Brain structural profile of multiple system atrophy patients with cognitive impairment , 2017, Journal of Neural Transmission.
[8] D. Dickson,et al. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy , 2017, Movement disorders : official journal of the Movement Disorder Society.
[9] D. Dickson,et al. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C , 2016, Movement disorders : official journal of the Movement Disorder Society.
[10] D. Dickson,et al. When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.
[11] J. Cummings,et al. Concordance of the Montreal cognitive assessment with standard neuropsychological measures , 2015, Alzheimer's & dementia.
[12] Anthony J. Spychalla,et al. Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy , 2014, The Journal of Neuroscience.
[13] R. Kessels,et al. Development and reliability of the Indonesian Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) , 2014 .
[14] J. Olszewski,et al. Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 2014, Seminars in Neurology.
[15] D. Tulsky,et al. Memory functioning in individuals with traumatic brain injury: An examination of the Wechsler Memory Scale–Fourth Edition (WMS–IV) , 2013, Journal of clinical and experimental neuropsychology.
[16] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[17] D. Dickson,et al. Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.
[18] Y. Agid,et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. , 2010, Brain : a journal of neurology.
[19] D. Dickson,et al. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. , 2008, Brain : a journal of neurology.
[20] A. Lees,et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.
[21] P. S. Mathuranath,et al. Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) , 2005, Neurocase.
[22] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[23] D. Dickson,et al. Microglial Activation Parallels System Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 2001, Journal of neuropathology and experimental neurology.
[24] P. Green,et al. Effort has a greater effect on test scores than severe brain injury in compensation claimants , 2001, Brain injury.
[25] M. Rohling. Generating a linear function for residual impairment for TBI: a comparison of the HRB and a flexible battery approach , 2000 .
[26] R. Spitzer,et al. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.
[27] K. Boone,et al. Handbook of Normative Data for Neuropsychological Assessment , 1999 .
[28] Jeffrey L. Cummings,et al. Neuropsychiatric aspects of progressive supranuclear palsy , 1996, Neurology.
[29] J. Hodges,et al. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy , 1996, Journal of Neurology.
[30] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[31] I Litvan,et al. Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.
[32] L. Golbe,et al. Psychiatric symptoms in progressive supranuclear palsy. , 1995, Psychosomatics.
[33] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[34] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[36] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Arie. Pseudodementia. , 1983, British medical journal.
[38] M. Albert,et al. The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.
[39] D. Watt,et al. Frontal-Subcortical Dementias , 2012 .
[40] D. Wechsler,et al. Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) , 2010 .
[41] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[42] 神田 信彦. Beck Depression Inventory-IIについての一考察 , 2004 .
[43] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.